Works by Thuss-Patience, Peter


Results: 49
    1
    2
    3
    4
    5
    6

    HER2 testing in gastric cancer: results of a German expert meeting.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 5, p. 835, doi. 10.1007/s00432-017-2374-x
    By:
    • Lordick, Florian;
    • Al-Batran, Salah-Eddin;
    • Dietel, Manfred;
    • Gaiser, Timo;
    • Hofheinz, Ralf-Dieter;
    • Kirchner, Thomas;
    • Kreipe, Hans;
    • Lorenzen, Sylvie;
    • Möhler, Markus;
    • Quaas, Alexander;
    • Röcken, Christoph;
    • Rüschoff, Josef;
    • Tannapfel, Andrea;
    • Thuss-Patience, Peter;
    • Baretton, Gustavo
    Publication type:
    Article
    7
    8
    9

    Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction.

    Published in:
    Cancer Immunology, Immunotherapy, 2014, v. 63, n. 12, p. 1273, doi. 10.1007/s00262-014-1596-x
    By:
    • Kuehnle, Marie-Cristine;
    • Attig, Sebastian;
    • Britten, Cedrik;
    • Schulze-Bergkamen, Henning;
    • Lordick, Florian;
    • Wichert, Goetz;
    • Thuss-Patience, Peter;
    • Stein, Alexander;
    • Schuler, Martin;
    • Bassermann, Florian;
    • Sahin, Ugur;
    • Türeci, Özlem
    Publication type:
    Article
    10
    11

    Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.

    Published in:
    2016
    By:
    • Moehler, Markus;
    • Gepfner-Tuma, Irina;
    • Maderer, Annett;
    • Thuss-Patience, Peter C.;
    • Ruessel, Joern;
    • Hegewisch-Becker, Susanna;
    • Wilke, Hansjochen;
    • Al-Batran, Salah-Eddin;
    • Rafiyan, Mohammad-Reza;
    • Weiβinger, Florian;
    • Schmoll, Hans-Joachim;
    • Kullmann, Frank;
    • von Weikersthal, Ludwig Fischer;
    • Siveke, Jens T.;
    • Weusmann, Jens;
    • Kanzler, Stephan;
    • Schimanski, Carl Christoph;
    • Otte, Melanie;
    • Schollenberger, Lukas;
    • Koenig, Jochem
    Publication type:
    journal article
    12
    13
    14

    Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 21, p. 1667, doi. 10.1093/jnci/djt269
    By:
    • Paoletti, Xavier;
    • Oba, Koji;
    • Bang, Yung-Jue;
    • Bleiberg, Harry;
    • Boku, Narikazu;
    • Bouché, Olivier;
    • Catalano, Paul;
    • Fuse, Nozomu;
    • Michiels, Stefan;
    • Moehler, Markus;
    • Morita, Satoshi;
    • Ohashi, Yasuo;
    • Ohtsu, Atsushi;
    • Roth, Arnaud;
    • Rougier, Philippe;
    • Sakamoto, Junichi;
    • Sargent, Daniel;
    • Sasako, Mitsuru;
    • Shitara, Kohei;
    • Thuss-Patience, Peter
    Publication type:
    Article
    15

    Paclitaxel/Ramucirumab versus Paclitaxel in 2nd-Line Therapy of Advanced Esophageal Squamous Cell Carcinoma: Randomized Phase II IKF-AIO-RAMOS Trial.

    Published in:
    Oncology Research & Treatment, 2024, v. 47, n. 11, p. 549, doi. 10.1159/000541174
    By:
    • Scheck, Magdalena K.;
    • Goetze, Thorsten O.;
    • Ettrich, Thomas J.;
    • Schmalenberg, Harald;
    • Clemens, Michael;
    • Mahlberg, Rolf;
    • Heeg, Steffen;
    • Kanzler, Stephan;
    • Hapke, Gunnar;
    • Thuss-Patience, Peter;
    • Kestler, Angelika;
    • Treschl, Anne;
    • Heidel, Stefan;
    • Schiemer, Moritz;
    • Sookthai, Disorn;
    • Junge, Sabine;
    • Pauligk, Claudia;
    • Al-Batran, Salah-Eddin;
    • Lorenzen, Sylvie
    Publication type:
    Article
    16
    17

    Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 1, p. 152, doi. 10.1245/s10434-021-10508-x
    By:
    • Kurreck, Annika;
    • Gronau, Felix;
    • Alberto Vilchez, Miguel Enrique;
    • Abels, Wiltrud;
    • Enghard, Philipp;
    • Brandl, Andreas;
    • Francis, Roland;
    • Föhre, Bettina;
    • Lojewski, Christian;
    • Pratschke, Johann;
    • Thuss-Patience, Peter;
    • Modest, Dominik;
    • Rau, Beate;
    • Feldbrügge, Linda
    Publication type:
    Article
    18

    ASO Visual Abstract: Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin—A Single Center Observational Study.

    Published in:
    2021
    By:
    • Kurreck, Annika;
    • Gronau, Felix;
    • Alberto Vilchez, Miguel Enrique;
    • Abels, Wiltrud;
    • Enghard, Philipp;
    • Brandl, Andreas;
    • Francis, Roland;
    • Föhre, Bettina;
    • Lojewski, Christian;
    • Pratschke, Johann;
    • Thuss-Patience, Peter;
    • Modest, Dominik;
    • Rau, Beate;
    • Feldbrügge, Linda
    Publication type:
    Abstract
    19
    20

    Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 1, p. e2352830, doi. 10.1001/jamanetworkopen.2023.52830
    By:
    • Thuss-Patience, Peter;
    • Högner, Anica;
    • Goekkurt, Eray;
    • Stahl, Michael;
    • Kretzschmar, Albrecht;
    • Götze, Thorsten;
    • Stocker, Gertraud;
    • Reichardt, Peter;
    • Kullmann, Frank;
    • Pink, Daniel;
    • Bartels, Prisca;
    • Jarosch, Armin;
    • Hinke, Axel;
    • Schultheiß, Christoph;
    • Paschold, Lisa;
    • Stein, Alexander;
    • Binder, Mascha
    Publication type:
    Article
    21
    22
    23

    CT Body Composition of Sarcopenia and Sarcopenic Obesity: Predictors of Postoperative Complications and Survival in Patients with Locally Advanced Esophageal Adenocarcinoma.

    Published in:
    Cancers, 2021, v. 13, n. 12, p. 2921, doi. 10.3390/cancers13122921
    By:
    • Fehrenbach, Uli;
    • Wuensch, Tilo;
    • Gabriel, Pia;
    • Segger, Laura;
    • Yamaguchi, Takeru;
    • Auer, Timo Alexander;
    • Beetz, Nick Lasse;
    • Denecke, Christian;
    • Kröll, Dino;
    • Raakow, Jonas;
    • Knitter, Sebastian;
    • Chopra, Sascha;
    • Thuss-Patience, Peter;
    • Pratschke, Johann;
    • Hamm, Bernd;
    • Biebl, Matthias;
    • Geisel, Dominik
    Publication type:
    Article
    24
    25

    EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.

    Published in:
    2019
    By:
    • Wagner, Anna Dorothea;
    • Grabsch, Heike I.;
    • Mauer, Murielle;
    • Marreaud, Sandrine;
    • Caballero, Carmela;
    • Thuss-Patience, Peter;
    • Mueller, Lothar;
    • Elme, Annelie;
    • Moehler, Markus Hermann;
    • Martens, Uwe;
    • Kang, Yoon-Koo;
    • Rha, Sun Young;
    • Cats, Annemieke;
    • Tokunaga, Masanori;
    • Lordick, Florian
    Publication type:
    journal article
    26
    27
    28

    Efficacy of ramucirumab combination chemotherapy as second‐line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first‐line therapy.

    Published in:
    International Journal of Cancer, 2024, v. 154, n. 12, p. 2142, doi. 10.1002/ijc.34894
    By:
    • Masetti, Michael;
    • Al‐Batran, Salah‐Eddin;
    • Goetze, Thorsten O.;
    • Thuss‐Patience, Peter;
    • Knorrenschild, Jorge Riera;
    • Goekkurt, Eray;
    • Folprecht, Gunnar;
    • Ettrich, Thomas Jens;
    • Lindig, Udo;
    • Luley, Kim Barbara;
    • Pink, Daniel;
    • Dechow, Tobias;
    • Sookthai, Disorn;
    • Junge, Sabine;
    • Loose, Maria;
    • Pauligk, Claudia;
    • Lorenzen, Sylvie
    Publication type:
    Article
    29

    Pazopanib with 5‐FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase‐II study—The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO‐STO‐0510.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 6, p. 1007, doi. 10.1002/ijc.33864
    By:
    • Högner, Anica;
    • Al‐Batran, Salah‐Eddin;
    • Siveke, Jens T.;
    • Lorenz, Mario;
    • Bartels, Prisca;
    • Breithaupt, Kirstin;
    • Malfertheiner, Peter;
    • Homann, Nils;
    • Stein, Alexander;
    • Gläser, Dietrich;
    • Tamm, Ingo;
    • Hinke, Axel;
    • Vogel, Arndt;
    • Thuss‐Patience, Peter
    Publication type:
    Article
    30

    Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2‐positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group

    Published in:
    International Journal of Cancer, 2021, v. 149, n. 6, p. 1322, doi. 10.1002/ijc.33696
    By:
    • Hofheinz, Ralf‐Dieter;
    • Hegewisch‐Becker, Susanne;
    • Kunzmann, Volker;
    • Thuss‐Patience, Peter;
    • Fuchs, Martin;
    • Homann, Nils;
    • Graeven, Ullrich;
    • Schulte, Nadine;
    • Merx, Kirsten;
    • Pohl, Michael;
    • Held, Swantje;
    • Keller, Ralph;
    • Tannapfel, Andrea;
    • Al‐Batran, Salah‐Eddin
    Publication type:
    Article
    31

    Phase III randomized, double‐blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum‐containing regimen (RADPAC)

    Published in:
    International Journal of Cancer, 2020, v. 147, n. 9, p. 2493, doi. 10.1002/ijc.33025
    By:
    • Lorenzen, Sylvie;
    • Knorrenschild, Jorge Riera;
    • Pauligk, Claudia;
    • Hegewisch‐Becker, Susanna;
    • Seraphin, Jörg;
    • Thuss‐Patience, Peter;
    • Kopp, Hans‐Georg;
    • Dechow, Tobias;
    • Vogel, Arndt;
    • Luley, Kim Barbara;
    • Pink, Daniel;
    • Stahl, Michael;
    • Kullmann, Frank;
    • Hebart, Holger;
    • Siveke, Jens;
    • Egger, Matthias;
    • Homann, Nils;
    • Probst, Stephan;
    • Goetze, Thorsten Oliver;
    • Al‐Batran, Salah‐Eddin
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer.

    Published in:
    Gastric Cancer, 2024, v. 27, n. 1, p. 6, doi. 10.1007/s10120-023-01424-y
    By:
    • Lordick, Florian;
    • Al-Batran, Salah-Eddin;
    • Arnold, Dirk;
    • Borner, Markus;
    • Bruns, Christiane J.;
    • Eisterer, Wolfgang;
    • Faber, Gerhard;
    • Gockel, Ines;
    • Köberle, Dieter;
    • Lorenzen, Sylvie;
    • Möhler, Markus;
    • Pritzkuleit, Ron;
    • Stahl, Michael;
    • Thuss-Patience, Peter;
    • Wöll, Ewald;
    • Zander, Thomas;
    • Maschmeyer, Georg
    Publication type:
    Article
    38

    Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS).

    Published in:
    Gastric Cancer, 2022, v. 25, n. 3, p. 586, doi. 10.1007/s10120-021-01271-9
    By:
    • Shitara, Kohei;
    • Doi, Toshihiko;
    • Hosaka, Hisashi;
    • Thuss-Patience, Peter;
    • Santoro, Armando;
    • Longo, Federico;
    • Ozyilkan, Ozgur;
    • Cicin, Irfan;
    • Park, David;
    • Zaanan, Aziz;
    • Pericay, Carles;
    • Özgüroğlu, Mustafa;
    • Alsina, Maria;
    • Makris, Lukas;
    • Benhadji, Karim A.;
    • Ilson, David H.
    Publication type:
    Article
    39

    Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.

    Published in:
    Gastric Cancer, 2022, v. 25, n. 1, p. 197, doi. 10.1007/s10120-021-01227-z
    By:
    • Fuchs, Charles S.;
    • Özgüroğlu, Mustafa;
    • Bang, Yung-Jue;
    • Di Bartolomeo, Maria;
    • Mandala, Mario;
    • Ryu, Min-Hee;
    • Fornaro, Lorenzo;
    • Olesinski, Tomasz;
    • Caglevic, Christian;
    • Chung, Hyun C.;
    • Muro, Kei;
    • Van Cutsem, Eric;
    • Elme, Anneli;
    • Thuss-Patience, Peter;
    • Chau, Ian;
    • Ohtsu, Atsushi;
    • Bhagia, Pooja;
    • Wang, Anran;
    • Shih, Chie-Schin;
    • Shitara, Kohei
    Publication type:
    Article
    40

    Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.

    Published in:
    Gastric Cancer, 2021, v. 24, n. 4, p. 970, doi. 10.1007/s10120-021-01156-x
    By:
    • Mansoor, Wasat;
    • Arkenau, Hendrik-Tobias;
    • Alsina, Maria;
    • Shitara, Kohei;
    • Thuss-Patience, Peter;
    • Cuffe, Sinead;
    • Dvorkin, Mikhail;
    • Park, David;
    • Ando, Takayuki;
    • Van Den Eynde, Marc;
    • Beretta, Giordano D.;
    • Zaniboni, Alberto;
    • Doi, Toshihiko;
    • Tabernero, Josep;
    • Ilson, David H.;
    • Makris, Lukas;
    • Benhadji, Karim A.;
    • Van Cutsem, Eric
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48

    Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).

    Published in:
    2020
    By:
    • Tintelnot, Joseph;
    • Goekkurt, Eray;
    • Binder, Mascha;
    • Thuss-Patience, Peter;
    • Lorenzen, Sylvie;
    • Knorrenschild, Jorge Riera;
    • Kretzschmar, Albrecht;
    • Ettrich, Thomas;
    • Lindig, Udo;
    • Jacobasch, Lutz;
    • Pink, Daniel;
    • Al-Batran, Salah-Eddin;
    • Hinke, Axel;
    • Hegewisch-Becker, Susanna;
    • Nilsson, Sven;
    • Bokemeyer, Carsten;
    • Stein, Alexander
    Publication type:
    journal article
    49

    High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.

    Published in:
    2020
    By:
    • Fehr, Martin;
    • Hawle, Hanne;
    • Hayoz, Stefanie;
    • Thuss-Patience, Peter;
    • Schacher, Sabina;
    • Riera Knorrenschild, Jorge;
    • Dürr, Donat;
    • Knoefel, Wolfram T.;
    • Rumpold, Holger;
    • Bitzer, Michael;
    • Zweifel, Martin;
    • Samaras, Panagiotis;
    • Mey, Ulrich;
    • Küng, Marc;
    • Winterhalder, Ralph;
    • Eisterer, Wolfgang;
    • Hess, Viviane;
    • Gérard, Marie-Aline;
    • Templeton, Arnoud;
    • Stahl, Michael
    Publication type:
    journal article